LB-P8

DB18535InvestigationalOrganism Based Therapies

LB-P8 is an investigational live biotherapeutic product consisting of a single bacterial strain (Leuconostoc citreum).

Code names
LB-P8

What you can answer from here — as of April 23, 2025

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of LB-P8, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In